Cargando…

A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma

BACKGROUND: The tumour heterogeneous make-up of immune cell infiltrates is a key factor for the therapy response and prognosis of hepatocellular carcinoma (HCC). However, it is still a major challenge to comprehensively understand the tumour immune microenvironment (TIME) at the genetic and cellular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Juan, Chen, Yanfei, Zhang, Xiaoqian, Guo, Jing, Xu, Kaijin, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787928/ https://www.ncbi.nlm.nih.gov/pubmed/35078458 http://dx.doi.org/10.1186/s12935-022-02469-2

Ejemplares similares

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

High CENPM mRNA expression and its prognostic significance in hepatocellular carcinoma: a study based on data mining
por: Wu, Zeng-hong, et al.
Publicado: (2020)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma
por: Lin, Zhen, et al.
Publicado: (2021)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma
por: Wang, Ben, et al.
Publicado: (2021)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection
por: Wu, Wenlong, et al.
Publicado: (2021)

RNA sequencing analysis reveals the competing endogenous RNAs interplay in resected hepatocellular carcinoma patients who received interferon-alpha therapy
por: Wu, Yibin, et al.
Publicado: (2021)

Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
por: Luo, Yangkun, et al.
Publicado: (2016)

Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma
por: Pang, Yilin, et al.
Publicado: (2021)

A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma
por: Chen, Binghai, et al.
Publicado: (2021)

Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma
por: Sun, Xiang-Hong, et al.
Publicado: (2020)

FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma
por: Chen, Jinzhang, et al.
Publicado: (2020)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Significance of PRO2000/ANCCA expression, a novel proliferation-associated protein in hepatocellular carcinoma
por: Yang, Jie, et al.
Publicado: (2014)

Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma
por: Wang, Zhihui, et al.
Publicado: (2021)

Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
por: Xu, Yu-Jie, et al.
Publicado: (2021)

RNA sequencing reveals the expression profiles of circRNA and identifies a four-circRNA signature acts as a prognostic marker in esophageal squamous cell carcinoma
por: Wang, Weiwei, et al.
Publicado: (2021)

Identification of a three-miRNA signature as a novel prognostic model for papillary renal cell carcinoma
por: Li, Ge, et al.
Publicado: (2020)

MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1
por: Gu, Junsheng, et al.
Publicado: (2019)

Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2
por: Guo, Jianping, et al.
Publicado: (2018)

Whole exome sequencing of a single osteosarcoma case—integrative analysis with whole transcriptome RNA-seq data
por: Reimann, Ene, et al.
Publicado: (2014)

Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma
por: Zeng, Zhiyong, et al.
Publicado: (2021)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

Screening and verification of long noncoding RNA promoter methylation sites in hepatocellular carcinoma
por: Lin, Zhuo, et al.
Publicado: (2020)

NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
por: Le, Yong, et al.
Publicado: (2019)

Spatial maps of hepatocellular carcinoma transcriptomes highlight an unexplored landscape of heterogeneity and a novel gene signature for survival
por: Zhao, Nan, et al.
Publicado: (2022)

A novel role of Krüppel-like factor 8 as an apoptosis repressor in hepatocellular carcinoma
por: Wang, Ming-Da, et al.
Publicado: (2020)

Circular RNA hsa_circ_0000517 modulates hepatocellular carcinoma advancement via the miR-326/SMAD6 axis
por: He, Shuwei, et al.
Publicado: (2020)

Two predictive precision medicine tools for hepatocellular carcinoma
por: Zhang, Zhiqiao, et al.
Publicado: (2019)

Identification and integrative analysis of ACLY and related gene panels associated with immune microenvironment reveal prognostic significance in hepatocellular carcinoma
por: Xu, Yunfeng, et al.
Publicado: (2021)

Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo
por: Cheung, Phyllis Fung-Yi, et al.
Publicado: (2014)

Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma
por: Li, Ping, et al.
Publicado: (2019)

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
por: zhang, Lan, et al.
Publicado: (2020)

The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma
por: Yu, Zhi-Hao, et al.
Publicado: (2021)

DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kcu412ohgip7s6tdnn6u7jp64m